Rezolute (RZLT) Gains from Investment Securities (2018 - 2021)
Rezolute (RZLT) posted Gains from Investment Securities of $14000.0 for Q1 2021, up 255.56% sequentially from -$9000.0 in Q4 2020, and up 158.33% YoY from $5419.4 in Q1 2020.
Rezolute (RZLT) Gains from Investment Securities (2018 - 2021) Analysis & Trends
Rezolute has reported Gains from Investment Securities for 4 years, with the latest figure at $14000.0 in Q1 2021.
- Quarterly Gains from Investment Securities rose 158.33% year-over-year to $14000.0 in Q1 2021, while the trailing twelve-month figure through Jun 2021 was $8000.0 (down 89.87% YoY) and the FY2021 annual result came in at $8000.0, down 89.87% from the prior year.
- Gains from Investment Securities grew to $14000.0 in Q1 2021 per RZLT's latest filing, from -$9000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $98000.0 in Q4 2019 and troughed at -$24000.0 in Q1 2020.
- A 4-year average of $8745.9 and a median of $3000.0 in 2020 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2019 and 2020: Gains from Investment Securities jumped 9700.0% in 2019, then sank 700.0% in 2020.
- Over 4 years, Gains from Investment Securities stood at $1000.0 in 2018, then surged by 9700.0% to $98000.0 in 2019, then tumbled by 109.18% to -$9000.0 in 2020, then soared by 255.56% to $14000.0 in 2021.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered $14000.0, -$9000.0, and $3000.0 for Q1 2021, Q4 2020, and Q3 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Rezolute | 442.94 Mn | 442.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 14,000.00 |
| Mar 31, 2021 | 14,000.00 |
| Dec 31, 2020 | -9,000.00 |
| Dec 31, 2020 | -9,000.00 |
| Sep 30, 2020 | 3,000.00 |
| Sep 30, 2020 | 3,000.00 |
| Jun 30, 2020 | 3,000.00 |
| Jun 30, 2020 | 3,000.00 |
| Mar 31, 2020 | -24,000.00 |
| Mar 31, 2020 | -24,000.00 |
| Dec 31, 2019 | 98,000.00 |
| Dec 31, 2019 | 98,000.00 |
| Sep 30, 2019 | 2,000.00 |
| Sep 30, 2019 | 2,000.00 |
| Jun 30, 2019 | 2,000.00 |
| Jun 30, 2019 | 2,000.00 |
| Mar 31, 2019 | 4,000.00 |
| Mar 31, 2019 | 4,000.00 |
| Dec 31, 2018 | 1,000.00 |
| Dec 31, 2018 | 1,000.00 |